Rapid Testing Meets Respiratory Season

Host-response biomarkers may provide complementary information when pathogen-specific tests do not tell the full story

1

The 2025 flu season highlighted the need for rapid, accurate diagnostics to support timely treatment decisions in crowded clinical settings.
2

CLIA-waived rapid panel testing has expanded significantly, enabling quicker identification of respiratory pathogens like COVID-19 and influenza.
3

Multiplex testing improves laboratories' ability to differentiate between various respiratory pathogens, enhancing patient care.
4

Rapid diagnostics can help clinicians distinguish between bacterial and nonbacterial infections, supporting antimicrobial stewardship.
5

Rapid POC testing is viewed as complementary to central laboratory testing, enhancing overall diagnostic capabilities during respiratory seasons.

1